No Data
A Quick Look at Today's Ratings for Apellis Pharmaceuticals(APLS.US), With a Forecast Between $31 to $47
A Quick Look at Today's Ratings for Apellis Pharmaceuticals(APLS.US), With a Forecast Between $32 to $60
Apellis Pharmaceuticals Price Target Maintained With a $57.00/Share by HC Wainwright & Co.
Here's Why Apellis Pharmaceuticals (NASDAQ:APLS) Can Afford Some Debt
Apellis Pharmaceuticals Analyst Ratings
Piper Sandler Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS)